Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michelle Amundson
Observed name:
M L Amundson
Institution:
Mayo Clinic
Observed institutions:
Holy Name Medical Center,
Mayo Clinic
OpenAlex ID:
A5018932885
High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations
2024
·
Zhuoer Xie
, Jenna Fernandez
, et al.
·
Blood
·
18
PDF
Depression and chronic fatigue in the high school student and athlete.
1991
·
J E Lidstone
, M L Amundson
, et al.
·
PubMed
·
13
Relationship Between High School Athletic Participation and Adult Fitness and Metabolic Health
2017
·
Stephen Angeli
, Daniel Angeli
, et al.
·
Journal of the American College of Cardiology
·
4
Phase II trial assessing safety and preliminary efficacy of high-dose intravenous ascorbic acid in patients with TET2-mutant clonal cytopenias of undetermined significance.
2022
·
Zhuoer Xie
, Terra L. Lasho
, et al.
·
Journal of Clinical Oncology
·
3
Earlier CRS identification with continuous wearable monitoring in outpatient CAR T-cell therapy.
2026
·
Jonas Paludo
, Michael Pettinati
, et al.
·
Journal of Clinical Oncology
LS1781 (Arm E): Phase II clinical trial to assess the safety and efficacy of high dose IV ascorbic acid with decitabine in newly diagnosed TET2 mutant chronic myelomonocytic leukemia (CMML)
2025
·
Abhishek Mangaonkar
, Jenna Fernandez
, et al.
·
Blood
PDF
Relationship between High School Athletic Participation and Adult Fitness and Metabolic Health
2017
·
Stephen Angeli
, Michelle Amundson
, et al.
·
International Journal of Cardiovascular Research
Show more works
View as search
Works count:
7
Citation count:
38
H-index:
3
I10-index:
2
Year
Topic
Type